Leukapheresis Products Market Research Report - Global Forecast till 2027

Global Leukapheresis Products Research Report: By Type (Leukapheresis Devices, Leukapheresis Disposables), by Application (Research Applications, Therapeutic Applications), By End User (Blood Component Provider and Blood Center, Other) -Forecast Till 2027

ID: MRFR/MED/5303-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.


Market Scenario:


Global leukapheresis products market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period.


Leukapheresis is a procedure of removing abnormal white blood cells (WBCs) from the blood. Leukapheresis can be used as a treatment for certain types of leukemia or as the first step of chimeric antigen receptor (CAR) T-cell therapy. The growing number of blood donations, increasing prevalence of leukaemia, and demand for leukapheresis products in clinical research are some factors that are anticipated to propel the growth of the market. According to the Facts and Figures 2017-2018 by the Leukemia and Lymphoma Society, an estimated 1,345,123 people in the US are living with or in remission from leukemia, lymphoma or myeloma. On the other hand, the high cost of therapeutic leukapheresis, dearth of skilled professionals, and stringent donor recruitment criteria may hinder the market growth over the forecast period.


Segmentation:


The global leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.


The market, on the basis of application, has been segmented into research applications and therapeutic applications.


On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The leukapheresis products market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European leukapheresis products market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The leukapheresis products market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The leukapheresis products market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players:


Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, StemExpress and others are some of the key players in the global leukapheresis products market.


Regional Market Summary:
Global Leukapheresis Products Market Share (%), by Region, 2017



Source: America’s Blood Centers, White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the global leukapheresis products market owing to the growing number of blood donations, rising incidence and prevalence of leukaemia and growing demand for leukopaks in clinical research. According to the America’s Blood Centers, more than 15 million pints of blood are transfused in the US each year.


Europe is expected to hold the second largest position in the global leukapheresis products market. The market growth in this region is attributed to the increasing prevalence of leukemia and well-developed healthcare sector in the region. According to the Cancer Research UK, about 9,900 new cases of leukaemia were reported in UK in 2015.


The leukapheresis products market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major multinational pharma and biotech companies, and improvement in healthcare access.


The Middle East & Africa has the lowest share of the global leukapheresis products market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.


Global Leukapheresis Products Market, by Type



  • Leukapheresis Devices

  • Apheresis Devices

  • Leukapheresis Columns & Cell Separators

  • Leukoreduction Filters



  • Leukapheresis Disposables


Global Leukapheresis Products Market, by Application



  • Research Applications

  • Therapeutic Applications


Global Leukapheresis Products Market, by End User



  • Blood Component Providers and Blood Centers

  • Hospitals and Transfusion Centers

  • Others


Global Leukapheresis Products Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Global Leukapheresis Products Market, by Key Players



  • Haemonetics

  • Terumo BCT

  • Asahi Kasei Medical

  • STEMCELL Technologies

  • Macopharma

  • Caltag Medsystem

  • ZENBIO

  • Fresenius Kabi

  • PPA Research Group

  • StemExpress

  • HemaCare Corporation

  • ALLCells, LLC

  • Others


Intended Audience



  • Apheresis Device Manufacturers and Distributors

  • Leukapheresis Product Manufacturers and Distributors

  • Pharmaceutical and Biotechnological Companies

  • Healthcare Service Providers (including Hospitals and Transfusion Centers)

  • Cancer Treatment Centers

  • Blood Component Providers & Blood Centers

  • Contract Research Organizations

  • Academic and Research Institutes

  • Government Associations



Frequently Asked Questions (FAQ) :


The leukapheresis products market is projected to grow at a 7.7% CAGR between 2018-2023.

The Americas is projected to command the largest share in the leukapheresis products market.

Rising prevalence of leukemia is boosting market growth.

Different strategies used by market players to create a dominance in the leukapheresis products market include product launches, collaborations, strategic alliances, and others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Leukapheresis Products Market, by Type

6.1 Introduction

6.2 Leukapheresis Devices

6.2.1 Apheresis Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2 Leukapheresis Columns & Cell Separators

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3 Leukoreduction Filters

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Leukapheresis Disposables

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Leukapheresis Products Market, by Application

7.1 Introduction

7.2 Research Applications

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Therapeutic Applications

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Leukapheresis Products Market, by End User

8.1 Introduction

8.2 Blood Component Providers and Blood Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Hospitals and Transfusion Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Others

Chapter 9. Global Leukapheresis Products Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape


10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Haemonetics

11.1.1 Company Overview

11.1.2 Treatment Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Terumo BCT

11.2.1 Company Overview

11.2.2 Treatment Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Asahi Kasei Medical

11.3.1 Company Overview

11.3.2 Treatment Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 STEMCELL Technologies

11.4.1 Company Overview

11.4.2 Treatment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Macopharma

11.5.1 Company Overview

11.5.2 Treatment Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Caltag Medsystem

11.6.1 Company Overview

11.6.2 Treatment Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 ZENBIO

11.7.1 Overview

11.7.2 Treatment Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Fresenius Kabi

11.8.1 Overview

11.8.2 Treatment Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 PPA Research Group

11.9.1 Overview

11.9.2 Treatment Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 StemExpress

11.10.1 Overview

11.10.2 Treatment Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 HemaCare Corporation

11.11.1 Overview

11.11.2 Treatment Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 ALLCells, LLC

11.12.1 Overview

11.12.2 Treatment Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

13.1.1 From CEO’s View point

13.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Leukapheresis Products Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Leukapheresis Products Market Synopsis, 2020-2027

Table 2 Global Leukapheresis Products Market Estimates and Forecast, 2020-2027

(USD Million)

Table 3 Global Leukapheresis Products Market, by Region, 2020-2027 (USD Million)

Table 4 Global Leukapheresis Products Market, by Type, 2020-2027 (USD Million)

Table 5 Global Leukapheresis Products Market, by Application, 2020-2027 (USD Million)

Table 6 Global Leukapheresis Products Market, by End User, 2020-2027 (USD Million)

Table 7 North America: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)

Table 8 North America: Leukapheresis Products Market, by Application, 2020-2027 (USD Million)

Table 9 North America: Leukapheresis Products Market, by End User, 2020-2027 (USD Million)

Table 10 US: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)

Table 11 US: Leukapheresis Products Market, by Application, 2020-2027 (USD Million)

Table 12 US: Leukapheresis Products Market, by End User, 2020-2027 (USD Million)

Table 13 Canada: Leukapheresis Products Market,by Type, 2020-2027 (USD Million)

Table 14 Canada: Leukapheresis Products Market,by Application, 2020-2027 (USD Million)


Table 15 Canada: Leukapheresis Products Market, by End User, 2020-2027 (USD Million)

Table 16 South America: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)

Table 17 South America: Leukapheresis Products Market, by Application, 2020-2027 (USD

Million)

Table 18 South America: Leukapheresis Products Market, by End User, 2020-2027 (USD Million)

Table 19 Europe: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)

Table 20 Europe: Leukapheresis Products Market, by Application, 2020-2027 (USD Million)

Table 21 Europe: Leukapheresis Products Market, by End User, 2020-2027 (USD Million)

Table 22 Western Europe: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)

Table 23 Western Europe: Leukapheresis Products Market, by Application, 2020-2027 (USD

Million)

Table 24 Western Europe: Leukapheresis Products Market, by End User, 2020-2027 (USD

Million)

Table 25 Eastern Europe: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)

Table 26 Eastern Europe: Leukapheresis Products Market, by Application, 2020-2027 (USD

Million)

Table 27 Eastern Europe: Leukapheresis Products Market, by End User, 2020-2027 (USD

Million)

Table 28 Asia-Pacific: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)

Table 30 Asia-Pacific: Leukapheresis Products Market, by Application, 2020-2027 (USD Million)

Table 31 Asia-Pacific: Leukapheresis Products Market, by End User, 2020-2027 (USD

Million)

Table 32 Middle East & Africa: Leukapheresis Products Market, by Type, 2020-2027 (USD

Million)

Table 33 Middle East & Africa: Leukapheresis Products Market, by Application, 2020-2027 (USD

Million)

Table 34 Middle East & Africa: Leukapheresis Products Market, by End User, 2020-2027 (USD

Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Leukapheresis Products Market

Figure 3 Segmentation Market Dynamics for Global Leukapheresis Products Market

Figure 4 Global Leukapheresis Products Market Share, by Type, 2020

Figure 5 Global Leukapheresis Products Market Share, by Application, 2020

Figure 6 Global Leukapheresis Products Market Share, by End User, 2020

Figure 7 Global Leukapheresis Products Market Share, by Region, 2020

Figure 8 North America: Leukapheresis Products Market Share, by Country, 2020

Figure 9 Europe: Leukapheresis Products Market Share, by Country, 2020

Figure 10 Asia-Pacific: Leukapheresis Products Market Share, by Country, 2020

Figure 11 Middle East & Africa: Leukapheresis Products Market Share, by Country, 201

Figure 12 Global Leukapheresis Products Market: Company Share Analysis, 2020 (%)

Figure 13 Haemonetics: Key Financials

Figure 14 Haemonetics: Segmental Revenue

Figure 15 Haemonetics: Geographical Revenue

Figure 16 Terumo BCT: Key Financials

Figure 17 Terumo BCT: Segmental Revenue

Figure 18 Terumo BCT: Geographical Revenue

Figure 19 Asahi Kasei Medical: Key Financials

Figure 20 Asahi Kasei Medical: Segmental Revenue

Figure 21 Asahi Kasei Medical: Geographical Revenue

Figure 22 STEMCELL Technologies : Key Financials

Figure 23 STEMCELL Technologies: Segmental Revenue

Figure 24 STEMCELL Technologies : Geographical Revenue

Figure 25 Macopharma: Key Financials

Figure 26 Macopharma: Segmental Revenue

Figure 27 Macopharma: Geographical Revenue

Figure 28 Caltag Medsystem: Key Financials

Figure 29 Caltag Medsystem: Segmental Revenue

Figure 30 Caltag Medsystem: Geographical Revenue

Figure 31 ZENBIO: Key Financials

Figure 32 ZENBIO: Segmental Revenue

Figure 33 ZENBIO: Geographical Revenue

Figure 34 Fresenius Kabi: Key Financials

Figure 35 Fresenius Kabi: Segmental Revenue

Figure 36 Fresenius Kabi: Geographical Revenue

Figure 37 PPA Research Group: Key Financials

Figure 38 PPA Research Group: Segmental Revenue

Figure 39 PPA Research Group: Geographical Revenue

Figure 40 StemExpress: Key Financials

Figure 41 StemExpress : Segmental Revenue

Figure 42 StemExpress: Geographical Revenue

Figure 43 HemaCare Corporation: Key Financials

Figure 44 HemaCare Corporation: Segmental Revenue

Figure 45 HemaCare Corporation: Geographical Revenue

Figure 46 ALLCells, LLC: Key Financials

Figure 47 ALLCells, LLC: Segmental Revenue

Figure 48 ALLCells, LLC: Geographical Revenue